Evaluation of intralesional Candida antigen in diabetic patients with multiple warts
| Autor: | Reham M Wahid, Rania Alakad, Ayman Marei |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Antigens Fungal medicine.medical_treatment Secondary infection Dermatology Injections Intralesional 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine CANDIDA ANTIGEN Diabetes mellitus Injection site Diabetes Mellitus Humans Medicine Sex organ Saline Candida business.industry virus diseases Immunotherapy medicine.disease Tolerability 030220 oncology & carcinogenesis Warts business |
| Zdroj: | Journal of Cosmetic Dermatology. 20:1248-1253 |
| ISSN: | 1473-2165 1473-2130 |
| DOI: | 10.1111/jocd.13718 |
| Popis: | BACKGROUND Treatment of warts in diabetic patients with ablative modalities poses a significant risk owing to increased possibility of secondary infection, slow healing, and recurrence. Intralesional immunotherapy has gained popularity in the treatment of warts due to its proven efficacy and good tolerability compared with destructive methods. AIM To evaluate the intralesional Candida antigen injection for the treatment of multiple warts in diabetic patients. PATIENTS/METHODS Fifty diabetic patients with multiple genital/nongenital warts were divided into two groups. The first group (30 patients) received intralesional Candida antigen, and the second group (20 patients) had intralesional saline as control. The treatments were injected into the largest wart every 2 weeks until complete clearance of warts or for a maximum of five sessions. RESULTS Complete clearance of warts was observed in 80% of the diabetic patients in the Candida antigen group compared with 15% in the control group (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|